The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merrimack; ZIOPHARM Oncology
Stock and Other Ownership Interests - Alexion Pharmaceuticals; ZIOPHARM Oncology
Demonstration of anti-tumor immunity via intratumoral regulated platform ad-RTS-hIL-12 in advanced breast cancer and recurrent glioblastoma patients.
 
Francois M. Lebel
Employment - ZIOPHARM Oncology
Leadership - ZIOPHARM Oncology
Stock and Other Ownership Interests - ZIOPHARM Oncology
 
John A Barrett
Employment - ZIOPHARM Oncology
Stock and Other Ownership Interests - ZIOPHARM Oncology
 
Heather L. McArthur
Consulting or Advisory Role - Amgen; Calithera Biosciences; Lilly; Merck; OBI Pharma; Peregrine Pharmaceuticals; Roche; Spectrum Pharmaceuticals; Syndax; TapImmune Inc.
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Calithera Biosciences; Lilly; Merck; OBI Pharma; Roche; Spectrum Pharmaceuticals
Other Relationship - Lilly; OBI Pharma
 
Jill Y. Buck
Employment - ZIOPHARM Oncology
Stock and Other Ownership Interests - Alexion Pharmaceuticals; ZIOPHARM Oncology
 
Nathan Demars
No Relationships to Disclose
 
Rich Mackenna
Employment - Catabasis; ZIOPHARM Oncology
Stock and Other Ownership Interests - Catabasis
 
Laurence JN Cooper
Employment - ZIOPHARM Oncology
Leadership - ZIOPHARM Oncology
Stock and Other Ownership Interests - Immatics; Intrexon; Taro; ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - City of Hope; Intrexon; MD Anderson Cancer Center; Sangamo Bioscience; ZIOPHARM Oncology
 
E. Antonio Chiocca
Consulting or Advisory Role - Alcyone; DNAtrix; ZIOPHARM Oncology
Research Funding - NIH/NCI